PHARMES BELGIË

Wielsbeke ·KBO/BCE: BE 1008.128.324

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	6.2%	43.4%	better than 11% of 2873 sector peers
Net result	€14k	€13k	better than 51% of 2872 sector peers
Equity	€18k	€44k	better than 26% of 2873 sector peers
Gross operating margin	€66k	€39k	better than 67% of 2870 sector peers
Staff costs	€25k	€30k	higher than 47% of 929 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€291k
Fixed assets	21/28	€119k
Intangible fixed assets	21	€37k
Tangible fixed assets	22/27	€81k
Current assets	29/58	€173k
Stocks & contracts in progress	3	€30k
Amounts receivable within one year	40/41	€106k
Cash & bank	54/58	€33k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€291k
Equity	10/15	€18k
Contributions / capital	10/11	€4k
Reserves	13	€14k
Amounts payable	17/49	€273k
Amounts payable after one year	17	€35k
Amounts payable within one year	42/48	€238k
Trade debts payable within one year	44	€170k
Income statement
Gross operating margin	9900	€66k
Operating result	9901	€21k
Financial income	75	€52
Financial charges	65	€3k
Result before taxes	9903	€19k
Income taxes	67/77	€5k
Net result for the period	9904	€14k
Result to be appropriated	9905	€14k

Summary